These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 24994009

  • 1. A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.
    Zhang J, Yin S, Guo F, Meng R, Chen C, Zhang H, Li Z, Fu Q, Shi H, Hu S, Ni W, Li T, Zhang K.
    J Microbiol; 2014 Aug; 52(8):681-8. PubMed ID: 24994009
    [Abstract] [Full Text] [Related]

  • 2. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z, Wang S, Zhang J, Yang G, Yuan B, Huang J, Han J, Xi L, Xiao Y, Chen C, Zhang H.
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
    Li Z, Wang S, Zhang H, Xi L, Zhang J, Zhang X, Zhou Q, Yi J, Li M, Zhang W, Zhang J.
    Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
    [Abstract] [Full Text] [Related]

  • 4. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
    Zhang J, Yin S, Yi D, Zhang H, Li Z, Guo F, Chen C, Fang W, Wang J.
    Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
    [Abstract] [Full Text] [Related]

  • 5. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J, Guo F, Chen C, Li Z, Zhang H, Wang Y, Zhang K, Du G, Li Y, Wang J, Jian T, Wang Z.
    Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
    [Abstract] [Full Text] [Related]

  • 6. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL, Cho Y, Kim K, Park BK, Hahn TW.
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [Abstract] [Full Text] [Related]

  • 7. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ, Manterola L, de Miguel MJ, Muñoz PM, Blasco JM, Moriyón I, López-Goñi I.
    Vaccine; 2006 Apr 05; 24(15):2910-6. PubMed ID: 16439039
    [Abstract] [Full Text] [Related]

  • 8. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
    Lalsiamthara J, Gogia N, Goswami TK, Singh RK, Chaudhuri P.
    Vaccine; 2015 May 21; 33(22):2577-83. PubMed ID: 25869887
    [Abstract] [Full Text] [Related]

  • 9. Immunization with recombinant GntR plasmid confers protection against Brucella challenge in BALB/c mice.
    Li Z, Wang S, Zhang H, Xi L, Zhang J, Zhang X, Han J, Zhang J.
    Microb Pathog; 2017 Oct 21; 111():357-361. PubMed ID: 28916314
    [Abstract] [Full Text] [Related]

  • 10. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ, Shi JX, Fu WD, Zhang Y, Zhang J, Wang Z, Li TS, Chen CF, Guo F, Zhang H.
    Mol Immunol; 2015 Aug 21; 66(2):276-83. PubMed ID: 25899866
    [Abstract] [Full Text] [Related]

  • 11. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y, Bai Y, Qu Q, Xu J, Chen Y, Zhong Z, Qiu Y, Wang T, Du X, Wang Z, Yu S, Fu S, Yuan J, Zhen Q, Yu Y, Chen Z, Huang L.
    Vet Microbiol; 2011 Aug 05; 151(3-4):354-62. PubMed ID: 21530111
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.
    Truong QL, Cho Y, Park S, Kim K, Hahn TW.
    Vaccine; 2016 Jan 04; 34(2):237-244. PubMed ID: 26616550
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Brucella abortus S19 rfbD mutant is highly attenuated, DIVA enable and confers protection against virulent challenge in mice.
    Lalsiamthara J, Kaur G, Gogia N, Ali SA, Goswami TK, Chaudhuri P.
    Biologicals; 2020 Jan 04; 63():62-67. PubMed ID: 31843357
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 04; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.